Nowell Solish

University of Toronto
Toronto, ON
Canada M5R 3N8
Email: n.solish@utoronto.ca

Papers:
Treatment of Moderate-to-Severe Glabellar Lines with Relabotulinumtoxina, a New Liquid Botulinum Toxin: Clinical Efficacy and Safety Results from the Ready-1 Phase III Trial